Pimwan ThongdeeJiraporn KuesapRaewadee WisedpanichkijKesara Na-BangchangThammasat UniversityMahidol University2018-12-112019-03-142018-12-112019-03-142016-09-01Asian Pacific Journal of Tropical Medicine. Vol.9, No.9 (2016), 856-859199576452-s2.0-84992694565https://repository.li.mahidol.ac.th/handle/20.500.14594/41177© 2016 Hainan Medical College Objective To preliminarily investigate the possible role of prostaglandin D2(PGD2) in malaria infections. Methods Blood and urinary samples (n = 120 each) were collected from Thai patients with Plasmodium falciparum (P. falciparum) with moderate (n = 26) and high (n = 4) parasitemia, patients with Plasmodium vivax (P. vivax) (n = 30), patients with fever associated with other infections (n = 30), and healthy subjects (n = 30). PGD2concentrations in plasma and urinary samples of healthy subjects, patients with fever associated with other infections and patients with malaria were determined using Prostaglandin D2-MOX express EIA kit (Cayman Chemical, USA). Results The possible association between PGD2and malaria infections is clearly demonstrated with PGD2concentration in urine. The urinary PGD2concentrations were relatively high (about 5-fold) in patients with P. falciparum with moderate parasitemia and P. vivax infections compared with other groups. Furthermore, the concentration in patients with P. falciparum with moderate parasitemia and P. vivax infection were significantly higher than that in healthy subjects and patients with fever associated with other infections. Conclusions Urinary PGD2concentrations may offer a more dependable and useful tool for predicting malaria severity. Confirmation is this preliminary finding is required with a larger sample size.Mahidol UniversityMedicineArticleSCOPUS10.1016/j.apjtm.2016.07.006